0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Sign in to save

The potential roles of interleukin-25 in infectious diseases

Frontiers in Immunology 2022 11 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 45 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Jing Wu Fang Zhang, Hongji Tao, Hongji Tao, Waqas Nawaz, Deyan Chen, Zhiwei Wu, Jing Wu

Summary

This review examined the roles of interleukin-25 (IL-25) in infectious disease contexts, summarizing evidence that this cytokine bridges innate and adaptive immunity and influences responses to parasitic, bacterial, and viral pathogens. The authors identified IL-25 as a potential therapeutic target given its regulatory role in type 2 immune responses.

Body Systems

Interleukin-25 (IL-25), also known as IL-17E, is a recently identified cytokine of the IL-17 family. Numerous studies illustrated that the expression of IL-25 is regulated by multiple pathogens, including parasitic, viral, and bacterial infections. IL-25 has a dual function in infectious diseases. On the one hand, IL-25 activates type 2 immunity <i>via</i> the relevant cytokines, including IL-4, IL-5, and IL-13, which are associated with the development of pathogenic infection-related allergic diseases. On the other hand, IL-25 involves in the recruitment of group 2 innate lymphoid cells (ILC2) to enhanced T helper 2 (Th2) cell differentiation, which are important to the clearance of pathogens. However, the precise roles of IL-25 in infectious diseases remain largely unknown. Thus, the current review will shed light on the pivotal roles of IL-25 in infectious diseases.

Sign in to start a discussion.

Share this paper